Affymetrix Inc. (AFFX)

[surf1944]

7:34AM Affymetrix and ScreenCell announce worldwide distribution agreement for Circulating Tumor Cell technology (AFFX) 5.08 : Co and ScreenCell announced the signing of a worldwide distribution agreement for ScreenCell's isolation devices and dilution buffers, designed for the collection of Circulating Tumor Cells in peripheral blood. The agreement makes Affymetrix the exclusive distributor of ScreenCell products used in combination with in situ hybridization assays, microarray assays, and other non-PCR based nucleic acid assays including Affymetrix' QuantiGene ViewRNA Assays, QuantiGene Plex Assays, and GeneChip Microarray Assays. The QuantiGene ViewRNA CTC platform, consist of ScreenCell's products and Affymetrix' QuantiGene ViewRNA Assays, is now available from Affymetrix.